Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient care

Gate2Brain at MIT Pitch Day at University of Cambridge

Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day at the University…
medicines beyond barriersG2B

Medicines beyond barriers

At Gate2Brain, we have found the key to unlocking the gate to the brain . We have developed a unique…
EITHealth Catapult 2022eithealth

Gate2Brain semifinalist of EITHealth’s Catapult 2022

We’re proud to share that Gate2Brain is semifinalist of EITHealth's Catapult 2022. Thanks to…
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell TeixidĂł, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEM

Exploration Science with Dr. Wendy Harsock

Within the framework of the discussion-based interview series, Exploration Science, in which scientists…
Una tecnología para ayudar a tratar el cáncer infantilgate2brain

A technology to help treat pediatric cancer

,
Una tecnología para ayudar a tratar el cáncer infantil Expansión. Madrid . La tecnología de…
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.

Gate2Brain will be attending The Investment Readiness Series

,
On the 4th of July, Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series,…

Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

,
Meritxell Teixidó: “Una gran quantitat de fàrmacs no arriben al cervell, i la tecnologia de Gate2Brain…
Gate2Brain is delighted to be attending next week's #AseBioInvestorDay2022, organised by Asociación Española de Bioempresas in Madrid.Gate2Brain

Gate2Brain attending Asebio Investor Day 2022

,
Gate2Brain is delighted to be attending next week's #AseBioInvestorDay2022, organised by Asociación…
This past October, the i4KIDS Pediatric Innovation Hub hosted the Pediatric Innovation Day. Here is a video from Gate2Brain introducing its technology for pediatric brain tumors as one of the six finalist projects in the innovation competition. This fantastic and valuable initiative is organized by i4KIDS, an innovation-support Hub intended to identify pediatric and maternal health projects with the greatest potential in order to bring them closer to the market. The Hub is coordinated by Sant Joan de Déu Barcelona Children’s Hospital, In 2021, the #PediatricInnovationDay showcased some of the many innovative and challenging projects that are currently carried out in the field of pediatrics.

Gate2Brain Finalist Project at i4KIDS

This past October, the i4KIDS Pediatric Innovation Hub hosted the Pediatric Innovation Day. Here is…

‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer

,
Estas proteínas 'tractor' remolcan los fármacos hasta el cerebro como terapia contra un cáncer infantil…
Els valors de la Universitat La UB reivindica la seva identitatUniversitat de Barcelona

Gate2Brain’s CEO part of the values campaign of the University of Barcelona under the motto “I am Innovative”

Els valors de la Universitat La UB reivindica la seva identitat El transport públic, els mitjans de…
4YFN4YFN

GATE2BRAIN will be participating in 4YFN at the Mobile World Congress

Gate2Brain will participate in the next edition of 4 Years From Now (4YFN), the platform dedicated to…
doctorat industrial

An industrial doctorate is looking to transport drugs to the brain to treat cases of pediatric cancer so far incurable

,
LA COL·LABORACIÓ ENTRE L’INSTITUT DE RECERCA SANT JOAN DE DÉU (IRSJD - UB) I L’EMPRESA GATE2BRAIN…
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell TeixidĂł, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo TecnolĂłgico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere

Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation

Next Wednesday, February 16, Gate2Brain will be in Transfiere, European Forum for Science, Technology…
¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardia

How to transport drugs to the brain to treat pathologies?

,
El cerebro está protegido por la barrera hematoencefálica, que impide la entrada de bacterias, virus…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social